Grasim Industries fourth quarter net profit rises 13.3% to Rs 2,616 crore
Aditya Birla Group firm Grasim Industries Ltd on Monday reported a 13.3 per cent rise in its consolidated net profit to Rs 2,616.64 crore for the fourth quarter ended March 31. The company had posted a net profit of Rs 2,309.41 crore during the January-March quarter of the previous financial year, Grasim Industries said in a regulatory filing. READ MORE…
Market-cap of BSE-listed companies at record $3 trillion
BSE on Monday added another feather to its cap with the market capitalisation of all listed companies on the exchange reaching USD 3 trillion for the first time ever. At close of trade, the market capitalisation of BSE-listed companies stood at Rs 2,18,94,202.30 crore (USD 3 trillion). During the day, the market capitalisation of BSE-listed companies went past the Rs 219 lakh crore level. READ MORE…
Pfizer says it will supply Covid vaccine only to central govt, not states
After Moderna, another Covid-19 vaccine manufacturer, Pfizer, has refused to send direct vaccination to Punjab, citing its policy to only deal with the Central government, state Nodal Officer (Vaccination) Vikas Garg said on Monday. He said the company, in a communication to the state, said: “Pfizer is working with federal governments across the world to supply its Covid-19 vaccine for use in national immunisation programmes.” READ MORE…
Panacea Biotec to produce 100 mn doses of Sputnik V per year
The Russian Direct Investment Fund (RDIF) and Indian drug firm Panacea Biotec on Monday announced the launch of production of the Sputnik V coronavirus vaccine in India. The first batch of the COVID-19 vaccine produced at Panacea Biotec’s facilities at Baddi in Himachal Pradesh will be shipped to the Russia’s Gamaleya Center for quality control. READ MORE…
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
Source link
